2023
DOI: 10.1089/thy.2023.0221
|View full text |Cite
|
Sign up to set email alerts
|

International phase IV field study for the reliability and validity of the European Organisation for Research and Treatment of Cancer Thyroid Cancer Module EORTC QLQ-THY34

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 16 publications
0
4
0
Order By: Relevance
“…Two studies [ 34 , 41 ] solely included patients with and without hypoPT after treatment for thyroid cancer. Büttner et al [ 34 ] analyzed data from the development of thyroid cancer-specific EORTC thyroid module (EORTC QLQ-THY34) [ 51 ]. Seventeen patients with hypoPT at least nine months after treatment for thyroid cancer were compared to 72 controls without hypoPT at least 9 months after treatment for thyroid cancer using the EORTC QLQ-C30.…”
Section: Resultsmentioning
confidence: 99%
“…Two studies [ 34 , 41 ] solely included patients with and without hypoPT after treatment for thyroid cancer. Büttner et al [ 34 ] analyzed data from the development of thyroid cancer-specific EORTC thyroid module (EORTC QLQ-THY34) [ 51 ]. Seventeen patients with hypoPT at least nine months after treatment for thyroid cancer were compared to 72 controls without hypoPT at least 9 months after treatment for thyroid cancer using the EORTC QLQ-C30.…”
Section: Resultsmentioning
confidence: 99%
“…This analysis set out to investigate the effect of electronic versus paper-based data capture on the time and help needed to complete the questionnaires for a newly developed questionnaire to measure the quality of life in thyroid cancer patients [ 37 ]. We were also interested in whether the proportion of missing scores differs between these two options.…”
Section: Discussionmentioning
confidence: 99%
“…Institutional Review Board Approval was obtained from the Ethics Committee of Rhineland-Palatinate Medical Association with reference number 837.406.17 (11240) as well as from all participating sites, according to the respective national requirements. More details about the study design and conduct are published elsewhere [ 37 ].…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations